Literature DB >> 10199347

A pill a day, or two, for hepatitis B?

G Dusheiko1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10199347     DOI： 10.1016/S0140-6736(98)00294-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Treatment options for chronic hepatitis. Antivirals look promising.

Authors:  A J Zuckerman; D Lavanchy
Journal:  BMJ       Date:  1999-09-25

Review 2.  Resistance to lamivudine therapy: is there more than meets the eye?

Authors:  G Dusheiko; A Bertoletti
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 3.  Lamivudine. A review of its therapeutic potential in chronic hepatitis B.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.